Evidence map›Paper›PMID 38501195›Full record

ArticleThe Analyst2024

Rapid measurement of hemoglobin-oxygen dissociation by leveraging Bohr effect and Soret band bathochromic shift.

Zoe Sekyonda, Ran An, Utku Goreke, Yuncheng Man, Karamoja Monchamp, Allison Bode, Qiaochu Zhang, Yasmin El-Gammal, Cissy Kityo, Theodosia A Kalfa and 2 more

Abstract readValidation Study
In one paragraph

Article in The Analyst, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zoe SekyondaDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-8249-809X
Ran AnDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, 10900 Euclid Ave., Glennan Building 616B, Cleveland, OH, 44106, USA. umut@case.edu.ORCID http://orcid.org/0000-0002-4849-0120
Utku GorekeDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, 10900 Euclid Ave., Glennan Building 616B, Cleveland, OH, 44106, USA. umut@case.edu.ORCID http://orcid.org/0000-0001-7973-9120
Yuncheng ManDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, 10900 Euclid Ave., Glennan Building 616B, Cleveland, OH, 44106, USA. umut@case.edu.ORCID http://orcid.org/0000-0002-3034-5523
Karamoja MonchampDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, 10900 Euclid Ave., Glennan Building 616B, Cleveland, OH, 44106, USA. umut@case.edu.
Allison BodeDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, 10900 Euclid Ave., Glennan Building 616B, Cleveland, OH, 44106, USA. umut@case.edu.
Qiaochu ZhangDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, 10900 Euclid Ave., Glennan Building 616B, Cleveland, OH, 44106, USA. umut@case.edu.
Yasmin El-GammalDivision of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Cissy KityoThe Joint Clinical Research Center, Kampala, Uganda.ORCID http://orcid.org/0000-0002-9286-7052
Theodosia A KalfaDivision of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-0426-9686
Ozan AkkusDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-3523-3421
Umut A GurkanDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-0331-9960

Funding

Xenotransplant and Genome Editing CoreU54DK126108 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Daniel Starczynowski, YI ZHENG · 2021 to 2026
$5.0M
HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screeningR44HL140739 · NHLBI · HEMEX HEALTH, INC. · PI GALEN, PETER · 2018 to 2025
$4.7M
Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability (Administrative Supplement)R42HL162214 · NHLBI · BIOCHIP LABS, INC. · PI FEDERICI, CHIARA, GURKAN, UMUT A. · 2022 to 2024
$2.1M
Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testingR42DK119048 · NIDDK · HEMEX HEALTH, INC. · PI GALEN, PETER · 2022 to 2023
$1.7M
A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell DiseaseU01AI176469 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI GIANNIKOPOULOS, PETROS, GURKAN, UMUT A. · 2023 to 2025
$1.4M
Microfluidic Impedance Red Cell Assay (MIRCA) for Emerging Pharmacologic and Gene based Therapies for Sickle Cell DiseaseR56HL165946 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI GURKAN, UMUT A. · 2022 to 2022
$663k
Roles of Red Blood Cell Derived Extracellular Vesicles in Complement Activation and Thromboinflammation in Sickle Cell DiseaseK25HL159358 · NHLBI · UNIVERSITY OF HOUSTON · PI Ran An · 2022 to 2026
$532k
RHODA: Rapid Hemoglobin-Oxygen Dissociation AssayR41HL172662 · NHLBI · HEMEX HEALTH, INC. · PI GALEN, PETER, GURKAN, UMUT A. · 2024 to 2024
$296k
NHLBI NIH HHS K25 HL159358NHLBI NIH HHS R41 HL172662NHLBI NIH HHS R42 HL162214NHLBI NIH HHS R44 HL140739NHLBI NIH HHS R56 HL165946NIAID NIH HHS U01 AI176469NIDDK NIH HHS R42 DK119048NIDDK NIH HHS U54 DK126108
6 · The paper itself

Abstract

Oxygen (O

Indexed as

HemoglobinsOptics and PhotonicsOxygenHumansHydrogen-Ion ConcentrationHemoglobinsOxygen

Identifiers

PMID38501195
PMCPMC11056771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.